|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 2558592 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11717518.2 |
| Date of filing the European patent application | 2011-04-11 | |
| (97) | Date of publication of the European application | 2013-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/055579 |
| Date | 2011-04-11 |
| (87) | Number | WO 2011/128278 |
| Date | 2011-10-20 |
| (30) | Number | Date | Country code |
| 323502 P | 2010-04-13 | US |
| (72) |
CHU, Tom, US
ESSIOUX, Laurent, FR
GERMER, Soren, US
LOPATIN, Uri, US
SHULMAN, Nancy, US
THOMMES, James, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstra e 124, 4070 Basel,
CH
|
| (54) | SINGLE NUCLEOTIDE POLYMORPHISMS THAT PREDICT HCV TREATMENT OUTCOMES |
| SINGLE NUCLEOTIDE POLYMORPHISMS THAT PREDICT HCV TREATMENT OUTCOMES |